HIV-1 and interferons: who's interfering with whom?

被引:228
作者
Doyle, Tomas [1 ]
Goujon, Caroline [1 ]
Malim, Michael H. [1 ]
机构
[1] Kings Coll Hosp London, Dept Infect Dis, Guys Hosp, London SE1 9RT, England
基金
英国惠康基金; 美国国家卫生研究院; 英国医学研究理事会;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; INNATE IMMUNE SENSOR; PRIMARY HUMAN MACROPHAGES; INFECTED SOOTY MANGABEYS; CHRONIC HEPATITIS-C; T-CELLS; I INTERFERON; DENDRITIC CELLS; RESTRICTION FACTORS; INHIBITS HIV-1;
D O I
10.1038/nrmicro3449
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ability of interferons (IFNs) to inhibit HIV-1 replication in cell culture models has long been recognized, and the therapeutic administration of IFN alpha to HIV-1-infected patients who are not receiving antiretroviral therapy produces a clear but transient decrease in plasma viral load. Conversely, studies of chronic HIV-1 infection in humans and SIV-infected animal models of AIDS show positive correlations between elevated plasma levels of IFNs, increased expression of IFN-stimulated genes (ISGs), biomarkers of inflammation and disease progression. In this Review, we discuss the evidence that IFNs can control HIV-1 replication in vivo and debate the controversial role of IFNs in promoting the pathological sequelae of chronic HIV-1 infection.
引用
收藏
页码:403 / 413
页数:11
相关论文
共 114 条
[1]   Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics [J].
Albin, John S. ;
Harris, Reuben S. .
EXPERT REVIEWS IN MOLECULAR MEDICINE, 2010, 12
[2]   Interferon type I responses in primary and secondary infections [J].
Alsharifi, Mohammed ;
Muellbacher, Arno ;
Regner, Matthias .
IMMUNOLOGY AND CELL BIOLOGY, 2008, 86 (03) :239-245
[3]   Conserved footprints of APOBEC3G on hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences [J].
Armitage, Andrew E. ;
Katzourakis, Aris ;
de Oliveira, Tulio ;
Welch, John J. ;
Belshaw, Robert ;
Bishop, Kate N. ;
Kramer, Beatrice ;
McMichael, Andrew J. ;
Rambaut, Andrew ;
Iversen, Astrid K. N. .
JOURNAL OF VIROLOGY, 2008, 82 (17) :8743-8761
[4]   Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1-Monoinfected Participants: A Phase II Clinical Trial [J].
Asmuth, David M. ;
Murphy, Robert L. ;
Rosenkranz, Susan L. ;
Lertora, Juan J. L. ;
Kottilil, Shyam ;
Cramer, Yoninah ;
Chan, Ellen S. ;
Schooley, Robert T. ;
Rinaldo, Charles R. ;
Thielman, Nathan ;
Li, Xiao-Dong ;
Wahl, Sharon M. ;
Shore, Jessica ;
Janik, Jennifer ;
Lempicki, Richard A. ;
Simpson, Yaa ;
Pollard, Richard B. .
JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (11) :1686-1696
[5]   Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration [J].
Azzoni, Livio ;
Foulkes, Andrea S. ;
Papasavvas, Emmanouil ;
Mexas, Angela M. ;
Lynn, Kenneth M. ;
Mounzer, Karam ;
Tebas, Pablo ;
Jacobson, Jeffrey M. ;
Frank, Ian ;
Busch, Michael P. ;
Deeks, Steven G. ;
Carrington, Mary ;
O'Doherty, Una ;
Kostman, Jay ;
Montaner, Luis J. .
JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (02) :213-222
[6]   Analysis of Apoptosis of Memory T Cells and Dendritic Cells during the Early Stages of Viral Infection or Exposure to Toll-Like Receptor Agonists [J].
Bahl, Kapil ;
Huebner, Anette ;
Davis, Roger J. ;
Welsh, Raymond M. .
JOURNAL OF VIROLOGY, 2010, 84 (10) :4866-4877
[7]   Immunologic strategies for HIV-1 remission and eradication [J].
Barouch, Dan H. ;
Deeks, Steven G. .
SCIENCE, 2014, 345 (6193) :169-174
[8]   Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions [J].
Beignon, AS ;
McKenna, K ;
Skoberne, M ;
Manches, O ;
DaSilva, I ;
Kavanagh, DG ;
Larsson, M ;
Gorelick, RJ ;
Lifson, JD ;
Bhardwaj, N .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3265-3275
[9]   Positional cloning of the mouse retrovirus restriction gene Fv1 [J].
Best, S ;
LeTissier, P ;
Towers, G ;
Stoye, JP .
NATURE, 1996, 382 (6594) :826-829
[10]   Intracellular Toll-like Receptors [J].
Blasius, Amanda L. ;
Beutler, Bruce .
IMMUNITY, 2010, 32 (03) :305-315